APA (7th ed.) Citation

JM, W., L, H., C, R., CKW, D., M, Z., A, H., . . . KM, K. (2025). Long-term disease control in dedifferentiated liposarcoma: A case report on trabectedin priming followed by PD-1 inhibition. Frontiers in oncology, 14, 1518775. https://doi.org/10.3389/fonc.2024.1518775

Chicago Style (17th ed.) Citation

JM, Waldschmidt, et al. "Long-term Disease Control in Dedifferentiated Liposarcoma: A Case Report on Trabectedin Priming Followed by PD-1 Inhibition." Frontiers in Oncology 14 (2025): 1518775. https://doi.org/10.3389/fonc.2024.1518775.

MLA (9th ed.) Citation

JM, Waldschmidt, et al. "Long-term Disease Control in Dedifferentiated Liposarcoma: A Case Report on Trabectedin Priming Followed by PD-1 Inhibition." Frontiers in Oncology, vol. 14, 2025, p. 1518775, https://doi.org/10.3389/fonc.2024.1518775.